Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Matthew Mossanen, M.D.

Co-Author

This page shows the publications co-authored by Matthew Mossanen and Guru Sonpavde.
Connection Strength

1.927
  1. An economic analysis comparing health care resource use and cost of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin versus gemcitabine and cisplatin as neoadjuvant therapy for muscle invasive bladder cancer. Urol Oncol. 2021 Jun 20.
    View in: PubMed
    Score: 0.248
  2. Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration. BJU Int. 2021 Apr 28.
    View in: PubMed
    Score: 0.246
  3. Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical Cystectomy. Urology. 2020 Jan; 135:44-49.
    View in: PubMed
    Score: 0.220
  4. Examining the relationship between complications and perioperative mortality following radical cystectomy: a population-based analysis. BJU Int. 2019 07; 124(1):40-46.
    View in: PubMed
    Score: 0.213
  5. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter? Cancer. 2019 05 01; 125(9):1449-1458.
    View in: PubMed
    Score: 0.210
  6. Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories. World J Urol. 2019 Oct; 37(10):2059-2065.
    View in: PubMed
    Score: 0.207
  7. Treating Patients With Bladder Cancer: Is There an Ethical Obligation to Include Smoking Cessation Counseling? J Clin Oncol. 2018 Nov 10; 36(32):3189-3191.
    View in: PubMed
    Score: 0.205
  8. Current Staging Strategies for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma. Urol Clin North Am. 2018 May; 45(2):143-154.
    View in: PubMed
    Score: 0.200
  9. Clinical characterization of radiation-associated muscle-invasive bladder cancer. Urology. 2021 Apr 20.
    View in: PubMed
    Score: 0.061
  10. Contemporary Treatment Patterns for Non-muscle-invasive Bladder Cancer: Has the Use of Radical Cystectomy Changed in the BCG Shortage Era? Urology. 2021 Jan; 147:199-204.
    View in: PubMed
    Score: 0.059
  11. Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non-muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2020 12; 18(6):e651-e659.
    View in: PubMed
    Score: 0.057
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.